Is there a role for extended adjuvant neratinib with pCR after neoadjuvant chemotherapy in triple positive breast cancer?   

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at Winship Cancer Institute and Emory University School of Medicine
In patients with HR+, HER2+ breast cancer who achi...
Medical Oncologist at Northwestern Medicine Cancer Center at KishHealth
Sign in or Register to read more